$TXMD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in TherapeuticsMD, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in TherapeuticsMD, Inc.. Get notifications about new insider transactions in TherapeuticsMD, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 12 2021 | TXMD | TherapeuticsMD, In ... | Donegan Michael C | CAO and VP Finance | Option Exercise | M | 0.00 | 19,000 | 0 | 38,000 | |
| May 12 2021 | TXMD | TherapeuticsMD, In ... | Donegan Michael C | CAO and VP Finance | Sell | S | 1.04 | 4,842 | 5,036 | 14,158 | 19 K to 14.2 K (-25.48 %) |
| May 12 2021 | TXMD | TherapeuticsMD, In ... | Donegan Michael C | CAO and VP Finance | Buy | M | 0.00 | 19,000 | 0 | 19,000 | 0 to 19 K |
| May 12 2021 | TXMD | TherapeuticsMD, In ... | Walker Marlan D | General Counsel | Option Exercise | M | 0.00 | 50,500 | 0 | 101,000 | |
| May 12 2021 | TXMD | TherapeuticsMD, In ... | Walker Marlan D | General Counsel | Sell | S | 1.04 | 21,592 | 22,456 | 28,908 | 50.5 K to 28.9 K (-42.76 %) |
| May 12 2021 | TXMD | TherapeuticsMD, In ... | Walker Marlan D | General Counsel | Buy | M | 0.00 | 50,500 | 0 | 50,500 | 0 to 50.5 K |
| May 12 2021 | TXMD | TherapeuticsMD, In ... | BORKOWSKI EDWARD | EVP, Operations | Option Exercise | M | 0.00 | 103,500 | 0 | 207,000 | |
| May 12 2021 | TXMD | TherapeuticsMD, In ... | BORKOWSKI EDWARD | EVP, Operations | Sell | S | 1.04 | 44,252 | 46,022 | 59,248 | 103.5 K to 59.2 K (-42.76 %) |
| May 12 2021 | TXMD | TherapeuticsMD, In ... | BORKOWSKI EDWARD | EVP, Operations | Buy | M | 0.00 | 103,500 | 0 | 103,500 | 0 to 103.5 K |
| May 12 2021 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | Secretary/CEO of su ... | Option Exercise | M | 0.00 | 103,500 | 0 | 207,000 | |
| May 12 2021 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | Secretary/CEO of su ... | Sell | S | 1.04 | 44,252 | 46,022 | 1,752,703 | 1.8 M to 1.8 M (-2.46 %) |
| May 12 2021 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | Secretary/CEO of su ... | Buy | M | 0.00 | 103,500 | 0 | 1,796,955 | 1.7 M to 1.8 M (+6.11 %) |
| May 12 2021 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.00 | 158,334 | 0 | 316,666 | |
| May 12 2021 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 1.04 | 67,697 | 70,405 | 17,991,637 | 18.1 M to 18 M (-0.37 %) |
| May 12 2021 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.00 | 158,334 | 0 | 18,059,334 | 17.9 M to 18.1 M (+0.88 %) |
| Mar 08 2021 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | X | 0.24 | 179,000 | 43,748 | 0 | |
| Mar 08 2021 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Gift | G | 0.00 | 300,000 | 0 | 17,901,000 | 18.2 M to 17.9 M (-1.65 %) |
| Mar 08 2021 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Gift | G | 0.00 | 350,000 | 0 | 18,201,000 | 18.6 M to 18.2 M (-1.89 %) |
| Mar 08 2021 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Payment of Exercise | F | 1.46 | 29,964 | 43,747 | 18,551,000 | 18.6 M to 18.6 M (-0.16 %) |
| Mar 08 2021 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | X | 0.24 | 179,000 | 43,748 | 18,580,964 | 18.4 M to 18.6 M (+0.97 %) |
| Mar 08 2021 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | X | 0.24 | 179,000 | 43,748 | 0 | |
| Mar 08 2021 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Gift | G | 0.00 | 434,814 | 0 | 0 | 434.8 K to 0 (-100.00 %) |
| Mar 08 2021 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Payment of Exercise | F | 1.46 | 29,964 | 43,747 | 1,693,455 | 1.7 M to 1.7 M (-1.74 %) |
| Mar 08 2021 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | X | 0.24 | 179,000 | 43,748 | 1,723,419 | 1.5 M to 1.7 M (+11.59 %) |
| Nov 27 2020 | TXMD | TherapeuticsMD, In ... | Donegan Michael C | Chief Accounting Of ... | Option Exercise | A | 0.00 | 230,000 | 0 | 230,000 | |
| Nov 27 2020 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | A | 0.00 | 360,000 | 0 | 360,000 | |
| Nov 27 2020 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | A | 0.00 | 1 | 0 | 1 | |
| Jun 19 2020 | TXMD | TherapeuticsMD, In ... | BISARO PAUL | Director | Option Exercise | A | 0.00 | 96,864 | 0 | 96,864 | |
| Jun 19 2020 | TXMD | TherapeuticsMD, In ... | Thompson Tommy G | Director | Option Exercise | A | 0.00 | 145,296 | 0 | 145,296 | |
| Jun 19 2020 | TXMD | TherapeuticsMD, In ... | Russell Angus C. | Director | Option Exercise | A | 0.00 | 96,864 | 0 | 96,864 | |
| Jun 19 2020 | TXMD | TherapeuticsMD, In ... | Naughton Gail K | Director | Option Exercise | A | 0.00 | 96,864 | 0 | 96,864 | |
| Jun 19 2020 | TXMD | TherapeuticsMD, In ... | MUSING JULES A. | Director | Option Exercise | A | 0.00 | 96,864 | 0 | 96,864 | |
| Jun 19 2020 | TXMD | TherapeuticsMD, In ... | Ling Karen | Director | Option Exercise | A | 0.00 | 96,864 | 0 | 96,864 | |
| Jun 19 2020 | TXMD | TherapeuticsMD, In ... | Collins Cooper C. | Director | Option Exercise | A | 0.00 | 96,864 | 0 | 96,864 | |
| Jun 19 2020 | TXMD | TherapeuticsMD, In ... | CARROLL J MARTIN | Director | Option Exercise | A | 0.00 | 96,864 | 0 | 96,864 | |
| Jun 19 2020 | TXMD | TherapeuticsMD, In ... | DArecca James | Chief Financial Off ... | Option Exercise | A | 0.00 | 651,500 | 0 | 651,500 | |
| Jun 19 2020 | TXMD | TherapeuticsMD, In ... | DArecca James | Chief Financial Off ... | Option Exercise | A | 0.00 | 151,500 | 0 | 151,500 | |
| Jun 10 2020 | TXMD | TherapeuticsMD, In ... | Collins Cooper C. | Director | Buy | P | 1.45 | 47,500 | 68,875 | 140,000 | 92.5 K to 140 K (+51.35 %) |
| Jun 10 2020 | TXMD | TherapeuticsMD, In ... | Collins Cooper C. | Director | Buy | P | 1.45 | 26,500 | 38,425 | 92,500 | 66 K to 92.5 K (+40.15 %) |
| Jun 10 2020 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | P | 1.47 | 25,000 | 36,750 | 18,401,964 | 18.4 M to 18.4 M (+0.14 %) |
| Jun 10 2020 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | P | 1.41 | 21,000 | 29,610 | 18,376,964 | 18.4 M to 18.4 M (+0.11 %) |
| Jun 08 2020 | TXMD | TherapeuticsMD, In ... | Thompson Tommy G | Director | Buy | P | 1.13 | 8,700 | 9,831 | 699,600 | 690.9 K to 699.6 K (+1.26 %) |
| Jun 08 2020 | TXMD | TherapeuticsMD, In ... | BISARO PAUL | Director | Buy | P | 1.14 | 50,000 | 57,000 | 50,000 | 0 to 50 K |
| Jun 08 2020 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | P | 1.15 | 20,000 | 23,000 | 18,355,964 | 18.3 M to 18.4 M (+0.11 %) |
| Jun 08 2020 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | P | 1.16 | 10,000 | 11,600 | 18,335,964 | 18.3 M to 18.3 M (+0.05 %) |
| Apr 01 2020 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | A | 0.00 | 310,500 | 0 | 310,500 | |
| Apr 01 2020 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | A | 0.00 | 310,500 | 0 | 310,500 | |
| Apr 01 2020 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | A | 0.00 | 475,000 | 0 | 475,000 | |
| Apr 01 2020 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | A | 0.00 | 475,000 | 0 | 475,000 | |
| Apr 01 2020 | TXMD | TherapeuticsMD, In ... | Krassan Mitchell | Chief Strategy Offi ... | Option Exercise | A | 0.00 | 151,500 | 0 | 151,500 | |
| Apr 01 2020 | TXMD | TherapeuticsMD, In ... | Krassan Mitchell | Chief Strategy Offi ... | Option Exercise | A | 0.00 | 151,500 | 0 | 151,500 | |
| Apr 01 2020 | TXMD | TherapeuticsMD, In ... | Cartwright Daniel A | Chief Financial Off ... | Option Exercise | A | 0.00 | 151,500 | 0 | 151,500 | |
| Apr 01 2020 | TXMD | TherapeuticsMD, In ... | Cartwright Daniel A | Chief Financial Off ... | Option Exercise | A | 0.00 | 151,500 | 0 | 151,500 | |
| Apr 01 2020 | TXMD | TherapeuticsMD, In ... | Donegan Michael C | Vice President Fina ... | Option Exercise | A | 0.00 | 57,000 | 0 | 57,000 | |
| Apr 01 2020 | TXMD | TherapeuticsMD, In ... | Donegan Michael C | Vice President Fina ... | Option Exercise | A | 0.00 | 57,000 | 0 | 57,000 | |
| Feb 05 2020 | TXMD | TherapeuticsMD, In ... | Krassan Mitchell | Chief Strategy Offi ... | Option Exercise | M | 0.20 | 194,297 | 39,578 | 489,658 | |
| Feb 05 2020 | TXMD | TherapeuticsMD, In ... | Krassan Mitchell | Chief Strategy Offi ... | Option Exercise | M | 0.19 | 105,703 | 19,809 | 0 | |
| Feb 05 2020 | TXMD | TherapeuticsMD, In ... | Krassan Mitchell | Chief Strategy Offi ... | Sell | S | 2.26 | 300,000 | 676,920 | 0 | 300 K to 0 (-100.00 %) |
| Feb 05 2020 | TXMD | TherapeuticsMD, In ... | Krassan Mitchell | Chief Strategy Offi ... | Buy | M | 0.20 | 194,297 | 39,578 | 300,000 | 105.7 K to 300 K (+183.81 %) |
| Feb 05 2020 | TXMD | TherapeuticsMD, In ... | Krassan Mitchell | Chief Strategy Offi ... | Buy | M | 0.19 | 105,703 | 19,809 | 105,703 | 0 to 105.7 K |
| Oct 29 2019 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | P | 2.75 | 72,000 | 198,000 | 1,544,419 | 1.5 M to 1.5 M (+4.89 %) |
| Oct 29 2019 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | P | 2.75 | 72,000 | 198,000 | 1,544,419 | 1.5 M to 1.5 M (+4.89 %) |
| Oct 29 2019 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Buy | P | 2.75 | 36,000 | 99,000 | 98,000 | 62 K to 98 K (+58.06 %) |
| Oct 29 2019 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | P | 2.75 | 72,000 | 198,000 | 18,325,964 | 18.3 M to 18.3 M (+0.39 %) |
| Aug 30 2019 | TXMD | TherapeuticsMD, In ... | Donegan Michael C | Vice President Fina ... | Option Exercise | A | 2.73 | 120,000 | 327,600 | 120,000 | |
| Aug 30 2019 | TXMD | TherapeuticsMD, In ... | Krassan Mitchell | Chief Strategy Offi ... | Option Exercise | A | 2.73 | 300,000 | 819,000 | 300,000 | |
| Aug 30 2019 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | A | 2.73 | 400,000 | 1,092,000 | 400,000 | |
| Aug 30 2019 | TXMD | TherapeuticsMD, In ... | Donegan Michael C | Vice President Fina ... | Option Exercise | A | 2.73 | 120,000 | 327,600 | 120,000 | |
| Aug 30 2019 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | A | 2.73 | 300,000 | 819,000 | 300,000 | |
| Aug 30 2019 | TXMD | TherapeuticsMD, In ... | Krassan Mitchell | Chief Strategy Offi ... | Option Exercise | A | 2.73 | 300,000 | 819,000 | 300,000 | |
| Aug 30 2019 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | A | 2.73 | 1 | 3 | 1 | |
| Aug 30 2019 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | A | 2.73 | 400,000 | 1,092,000 | 400,000 | |
| Aug 30 2019 | TXMD | TherapeuticsMD, In ... | Cartwright Daniel A | Chief Financial Off ... | Option Exercise | A | 2.73 | 220,000 | 600,600 | 220,000 | |
| Aug 30 2019 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | A | 2.73 | 300,000 | 819,000 | 300,000 | |
| Aug 30 2019 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | A | 2.73 | 1 | 3 | 1 | |
| Aug 30 2019 | TXMD | TherapeuticsMD, In ... | Cartwright Daniel A | Chief Financial Off ... | Option Exercise | A | 2.73 | 220,000 | 600,600 | 220,000 | |
| Aug 26 2019 | TXMD | TherapeuticsMD, In ... | Russell Angus C. | Director | Buy | P | 2.77 | 10,000 | 27,700 | 93,500 | 83.5 K to 93.5 K (+11.98 %) |
| Aug 20 2019 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | P | 2.74 | 35,000 | 95,900 | 18,253,964 | 18.2 M to 18.3 M (+0.19 %) |
| Aug 19 2019 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | P | 2.93 | 10,000 | 29,300 | 3,582,373 | 3.6 M to 3.6 M (+0.28 %) |
| Aug 15 2019 | TXMD | TherapeuticsMD, In ... | Russell Angus C. | Director | Buy | P | 2.99 | 10,000 | 29,900 | 83,500 | 73.5 K to 83.5 K (+13.61 %) |
| Aug 15 2019 | TXMD | TherapeuticsMD, In ... | Russell Angus C. | Director | Buy | P | 2.76 | 25,000 | 69,000 | 73,500 | 48.5 K to 73.5 K (+51.55 %) |
| Aug 14 2019 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | P | 3.16 | 15,000 | 47,400 | 3,572,373 | 3.6 M to 3.6 M (+0.42 %) |
| Aug 14 2019 | TXMD | TherapeuticsMD, In ... | Barlow Jane F | Director | Buy | P | 3.18 | 3,144 | 9,998 | 3,144 | 0 to 3.1 K |
| Aug 13 2019 | TXMD | TherapeuticsMD, In ... | Thompson Tommy G | Director | Buy | P | 3.04 | 5,000 | 15,200 | 690,900 | 685.9 K to 690.9 K (+0.73 %) |
| Aug 13 2019 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Buy | P | 2.87 | 10,000 | 28,700 | 62,000 | 52 K to 62 K (+19.23 %) |
| Aug 12 2019 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | P | 2.96 | 52,405 | 155,119 | 18,218,964 | 18.2 M to 18.2 M (+0.29 %) |
| Aug 12 2019 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Gift | G | 0.00 | 200,000 | 0 | 18,166,559 | 18.4 M to 18.2 M (-1.09 %) |
| Jun 24 2019 | TXMD | TherapeuticsMD, In ... | Thompson Tommy G | Director | Option Exercise | A | 2.64 | 112,500 | 297,000 | 112,500 | |
| Jun 24 2019 | TXMD | TherapeuticsMD, In ... | SEGAL NICHOLAS | Director | Option Exercise | A | 2.64 | 75,000 | 198,000 | 75,000 | |
| Jun 24 2019 | TXMD | TherapeuticsMD, In ... | Russell Angus C. | Director | Option Exercise | A | 2.64 | 75,000 | 198,000 | 75,000 | |
| Jun 24 2019 | TXMD | TherapeuticsMD, In ... | MUSING JULES A. | Director | Option Exercise | A | 2.64 | 75,000 | 198,000 | 75,000 | |
| Jun 24 2019 | TXMD | TherapeuticsMD, In ... | LaPenta Robert V Jr | Director | Option Exercise | A | 2.64 | 75,000 | 198,000 | 75,000 | |
| Jun 24 2019 | TXMD | TherapeuticsMD, In ... | Collins Cooper C. | Director | Option Exercise | A | 2.64 | 75,000 | 198,000 | 75,000 | |
| Jun 24 2019 | TXMD | TherapeuticsMD, In ... | CARROLL J MARTIN | Director | Option Exercise | A | 2.64 | 75,000 | 198,000 | 75,000 | |
| Jun 24 2019 | TXMD | TherapeuticsMD, In ... | Barlow Jane F | Director | Option Exercise | A | 2.64 | 75,000 | 198,000 | 75,000 | |
| May 15 2019 | TXMD | TherapeuticsMD, In ... | Collins Cooper C. | Director | Buy | P | 3.33 | 30,000 | 99,870 | 66,000 | 36 K to 66 K (+83.33 %) |
| May 14 2019 | TXMD | TherapeuticsMD, In ... | Thompson Tommy G | Director | Buy | P | 3.34 | 2,400 | 8,016 | 685,900 | 683.5 K to 685.9 K (+0.35 %) |
| Mar 01 2019 | TXMD | TherapeuticsMD, In ... | MUSING JULES A. | Director | Sell | S | 5.80 | 17,400 | 100,920 | 5,000 | 22.4 K to 5 K (-77.68 %) |
| Dec 21 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,910 | 9,458 | 0 | |
| Dec 21 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 92,910 | |
| Dec 21 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 3.63 | 92,910 | 336,892 | 18,366,559 | 18.5 M to 18.4 M (-0.50 %) |
| Dec 21 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,910 | 9,458 | 18,459,469 | 18.4 M to 18.5 M (+0.51 %) |
| Dec 21 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 3.70 | 92,000 | 340,216 | 18,366,559 | 18.5 M to 18.4 M (-0.50 %) |
| Dec 21 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,458,559 | 18.4 M to 18.5 M (+0.50 %) |
| Dec 19 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 129,127 | 13,145 | 0 | |
| Dec 19 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 129,127 | 13,145 | 0 | |
| Dec 19 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 129,000 | 13,132 | 129,127 | |
| Dec 19 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 129,000 | 13,132 | 129,127 | |
| Dec 19 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 3.64 | 129,127 | 469,635 | 1,472,419 | 1.6 M to 1.5 M (-8.06 %) |
| Dec 19 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 3.64 | 129,127 | 469,635 | 1,472,419 | 1.6 M to 1.5 M (-8.06 %) |
| Dec 19 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 129,127 | 13,145 | 1,601,546 | 1.5 M to 1.6 M (+8.77 %) |
| Dec 19 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 129,127 | 13,145 | 1,601,546 | 1.5 M to 1.6 M (+8.77 %) |
| Dec 19 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 3.75 | 129,000 | 483,750 | 1,472,419 | 1.6 M to 1.5 M (-8.06 %) |
| Dec 19 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 3.75 | 129,000 | 483,750 | 1,472,419 | 1.6 M to 1.5 M (-8.06 %) |
| Dec 19 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 129,000 | 13,132 | 1,601,419 | 1.5 M to 1.6 M (+8.76 %) |
| Dec 19 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 129,000 | 13,132 | 1,601,419 | 1.5 M to 1.6 M (+8.76 %) |
| Dec 14 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | M | 0.10 | 91,910 | 9,356 | 0 | |
| Dec 14 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | M | 0.10 | 91,400 | 9,305 | 91,910 | |
| Dec 14 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Gift | G | 0.00 | 190,000 | 0 | 52,000 | 242 K to 52 K (-78.51 %) |
| Dec 14 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Sell | S | 4.12 | 91,910 | 378,577 | 6,557,371 | 6.6 M to 6.6 M (-1.38 %) |
| Dec 14 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Buy | M | 0.10 | 91,910 | 9,356 | 6,649,281 | 6.6 M to 6.6 M (+1.40 %) |
| Dec 14 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Sell | S | 4.18 | 91,400 | 381,961 | 6,557,371 | 6.6 M to 6.6 M (-1.37 %) |
| Dec 14 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Buy | M | 0.10 | 91,400 | 9,305 | 6,648,771 | 6.6 M to 6.6 M (+1.39 %) |
| Dec 10 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 184,910 | |
| Dec 10 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Option Exercise | M | 0.10 | 92,000 | 9,366 | 276,910 | |
| Dec 10 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 4.60 | 92,000 | 423,568 | 18,366,559 | 18.5 M to 18.4 M (-0.50 %) |
| Dec 10 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,458,559 | 18.4 M to 18.5 M (+0.50 %) |
| Dec 10 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Sell | S | 4.57 | 92,000 | 420,624 | 18,366,559 | 18.5 M to 18.4 M (-0.50 %) |
| Dec 10 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Buy | M | 0.10 | 92,000 | 9,366 | 18,458,559 | 18.4 M to 18.5 M (+0.50 %) |
| Dec 10 2018 | TXMD | TherapeuticsMD, In ... | Finizio Robert G | CEO | Gift | G | 0.00 | 27,000 | 0 | 18,366,559 | 18.4 M to 18.4 M (-0.15 %) |
| Dec 10 2018 | TXMD | TherapeuticsMD, In ... | Cartwright Daniel A | CFO | Option Exercise | M | 0.38 | 40,000 | 15,200 | 180,000 | |
| Dec 10 2018 | TXMD | TherapeuticsMD, In ... | Cartwright Daniel A | CFO | Sell | S | 4.57 | 40,000 | 182,800 | 40,000 | 80 K to 40 K (-50.00 %) |
| Dec 10 2018 | TXMD | TherapeuticsMD, In ... | Cartwright Daniel A | CFO | Buy | M | 0.38 | 40,000 | 15,200 | 40,000 | 0 to 40 K |
| Dec 06 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 129,000 | 13,132 | 258,127 | |
| Dec 06 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 129,000 | 13,132 | 387,127 | |
| Dec 06 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 4.57 | 129,000 | 589,530 | 1,472,419 | 1.6 M to 1.5 M (-8.06 %) |
| Dec 06 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 129,000 | 13,132 | 1,601,419 | 1.5 M to 1.6 M (+8.76 %) |
| Dec 06 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 4.98 | 129,000 | 642,162 | 1,472,419 | 1.6 M to 1.5 M (-8.06 %) |
| Dec 06 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 129,000 | 13,132 | 1,601,419 | 1.5 M to 1.6 M (+8.76 %) |
| Dec 04 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | M | 0.10 | 91,400 | 9,305 | 183,310 | |
| Dec 04 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Option Exercise | M | 0.10 | 91,400 | 9,305 | 274,710 | |
| Dec 04 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Sell | S | 5.18 | 91,400 | 473,452 | 6,557,371 | 6.6 M to 6.6 M (-1.37 %) |
| Dec 04 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Buy | M | 0.10 | 91,400 | 9,305 | 6,648,771 | 6.6 M to 6.6 M (+1.39 %) |
| Dec 04 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Sell | S | 4.96 | 91,400 | 453,344 | 6,557,371 | 6.6 M to 6.6 M (-1.37 %) |
| Dec 04 2018 | TXMD | TherapeuticsMD, In ... | Bernick Brian | Director | Buy | M | 0.10 | 91,400 | 9,305 | 6,648,771 | 6.6 M to 6.6 M (+1.39 %) |
| Nov 30 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 129,128 | 13,145 | 516,127 | |
| Nov 30 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Option Exercise | M | 0.10 | 129,000 | 13,132 | 645,255 | |
| Nov 30 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 5.03 | 129,128 | 650,030 | 1,472,419 | 1.6 M to 1.5 M (-8.06 %) |
| Nov 30 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Buy | M | 0.10 | 129,128 | 13,145 | 1,601,547 | 1.5 M to 1.6 M (+8.77 %) |
| Nov 30 2018 | TXMD | TherapeuticsMD, In ... | Milligan John C.K. IV | President/Secretary | Sell | S | 4.89 | 129,000 | 630,294 | 1,472,419 | 1.6 M to 1.5 M (-8.06 %) |